33557-57-2

Usage

Uses

3-Methylpiperidin-4-ol is used in the treatment of BAF complex-related disorders.

InChI:InChI=1/C6H13NO/c1-5-4-7-3-2-6(5)8/h5-8H,2-4H2,1H3

Upstream product

• 91600-19-0 (rac)-1-Benzyl-3-methyl-piperidin-4-ol 
• 181269-70-5 trans-tert-butyl-4-hydroxy-3-methylpiperidine-1-carboxylate 
• 181269-69-2 tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate 
• 1159982-52-1 C₁₄H₂₃NO₅ 

Downstream Products

• 181269-70-5 trans-tert-butyl-4-hydroxy-3-methylpiperidine-1-carboxylate 
• 1610033-60-7 2-((2S,4R)-1-(4-(((3,4-trans)-1-(2-fluoro-5-methoxyphenyl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methoxypyrrolidin-2-yl)acetonitrile 
• 1610033-59-4 ((2R,4R)-1-(4-(((3,4-trans)-1-(2-fluoro-5-methoxyphenyl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methoxypyrrolidin-2-yl)methanol 

Relevant academic research and scientific papers

HEPATITIS B ANTIVIRAL AGENTS

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT

A chemical compound represented by the formula [I]: (wherein R 1 represents a hydroxyl group or the like, m represents 0 or an integer of 1 to 5, R 2 represents a halogen atom or the like, k represents 0 or an integer of 1 to 4, R 3 , R 31 , R 4 , R 41 ,

QUINOLONE ANTIBACTERIAL AGENTS

Compounds of formula (I, II, III, IV, V, and VI) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial agents.

Phencyclidine derivatives, preparation method and pharmaceutical compositions containing same

The invention concerns novel phenylcyclidine derivatives with selective affinity for low affinity receptors, methods for preparing them, pharmaceutical compositions containing them and their use as protective agents for central or peripheral nervous system cells against acute or chronic degeneration, or as an anticonvulsant.

Tetrahydroisoquinoline derivative and medical preparation containing the same

The present invention relates to a tetrahydroisoquinoline derivative represented by the following formula 1 exhibiting an inhibitory action for agglutination caused by fibrinogen, which may be effectively used as an antithrombotic agent or a platelet agglutination-inhibiting agent. The present invention also relates to a medical preparation containing such compound. STR1 In formula 1, B and G are an alkylene optionally substituted with an alkyl or the like; D is H, an alkyl, or the like; E is 1,2,3,4-tetrahydroisoquinoline optionally substituted with R1 to R4 which binds to G at position 2; R1 to R4 are an alkyl or the like; L is hydroxy or the like; and A is a substituent represented by formula (2), and C is carbon. STR2 In formula 2, M and R5 to R8 are H, an alkyl or the like.